Understanding The Potential Drug Target FoxRED2 (G80020)

Target Name: FOXRED2

NCBI ID: G80020

FOXRED2

Other Name(s): FAD dependent oxidoreductase domain containing 2 | FAD-dependent oxidoreductase domain containing 2, transcript variant 2 | endoplasmic reticulum flavoprotein associated with degradation | FAD-dependent oxidoreductase domain-containing protein 2 (isoform 1) | ER flavoprotein associated with degradation | FOXRED2 variant 1 | FOXRED2 variant 2 | FAD-dependent oxidoreductase domain-containing protein 2 | FAD dependent oxidoreductase domain containing 2, transcript variant 1 | ERFAD | Endoplasmic reticulum flavoprotein associated with degradation | FXRD2_HUMAN

Understanding The Potential Drug Target FoxRED2

FoxRED2 (FAD dependent oxidoreductase domain containing 2) is a protein that has been identified as a potential drug target or biomarker for a variety of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Its unique function as an antioxidant and its involvement in cellular processes make it an attractive target for drug development. In this article, we will explore the structure and function of FoxRED2 and its potential as a drug target.

Structure

FoxRED2 is a protein that contains a domain with oxidoreductase activity, a domain with catalytic activity, and a domain with structural stability. The oxidoreductase domain contains a catalytic center that is responsible for the reduction of reactive oxygen species (ROS) to non-reactive oxygen species (NO), which protects the cell from oxidative stress. The catalytic domain is responsible for the catalytic activity of the oxidoreductase domain and is involved in the chemical reaction that occurs within the cell. The structural stability domain is responsible for maintaining the stability of the protein and ensuring its stability in the cell.

Function

FoxRED2 is involved in a variety of cellular processes, including the detoxification of ROS, DNA damage repair, and cell signaling. Its antioxidant function protects the cell from oxidative stress caused by ROS. In addition, FoxRED2 is involved in the detoxification of DNA damage caused by UV radiation, which can lead to the development of cancer.

FoxRED2 is also involved in cell signaling, specifically in the regulation of cell growth and differentiation. Its activity in these processes is regulated by various factors, including the levels of growth factors and cellular signaling molecules.

Drug Targeting

FoxRED2 has been identified as a potential drug target due to its unique function and its involvement in a variety of diseases. Its antioxidant and signaling functions make it an attractive target for drug development.

One approach to targeting FoxRED2 is to use small molecules that inhibit its oxidoreductase activity. This would prevent the formation of NO, which is a potent antioxidant that can protect the cell from oxidative stress.

Another approach to targeting FoxRED2 is to use antibodies that recognize and target its catalytic domain. This would allow for the manipulation of the activity of FoxRED2 and could be useful for studying its function in cellular processes.

Conclusion

FoxRED2 is a protein that has been identified as a potential drug target or biomarker for a variety of diseases. Its unique function as an antioxidant and its involvement in cellular processes make it an attractive target for drug development. Further research is needed to fully understand its function and its potential as a drug.

Protein Name: FAD Dependent Oxidoreductase Domain Containing 2

Functions: Probable flavoprotein which may function in endoplasmic reticulum associated degradation (ERAD). May bind non-native proteins in the endoplasmic reticulum and target them to the ubiquitination machinery for subsequent degradation

The "FOXRED2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FOXRED2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets